Skip to main content
. 2022 Mar 25;14(7):1666. doi: 10.3390/cancers14071666

Figure 3.

Figure 3

Anticancer therapies most commonly reported in published cases of cancer patients with PI (Panel (A), only reported if occurrence was found in at least 3 patients) and number of cases grouped according to pharmacological class (Panel (B)) 5FU, fluorouracil; mAb monoclonal antibodies.